Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects

Site‐specific delivery of trophic factors in the brain may be important for achieving therapeutic efficacy without unwanted side effects. This study evaluated the site‐specific infusion of glial cell line–derived neurotrophic factor (GDNF) into the right putamen of aged rhesus monkeys. After 4 weeks of continuous infusion at a rate of 22.5 μg/day, GDNF had diffused up to 11 mm from the catheter openings in the putamen into the rostral putamen, internal capsule, external capsule, caudate nucleus, and globus pallidus. Anisotropic flow along the external capsule tracts carried GDNF into the anterior amygdaloid area. Backflow of GDNF along the catheter track from the frontal cortex infiltrated juxtaposed corpus callosal and cortical tissue. GDNF was carried by retrograde transport to dopamine neurons in the ipsilateral substantia nigra, stimulating an 18% increase in the number of tyrosine hydroxylase (TH)–positive dopamine neurons and a 28% increase in dopamine neuron perikaryal size. Also, TH‐positive fiber density was increased in the ipsilateral globus pallidus, caudate nucleus, and putamen. Anatomic effects from GDNF stimulation of the dopaminergic system were restricted to the ipsilateral hemisphere. Retrograde GDNF labeling was also present in a few TH‐positive neurons in the locus coeruleus and a large cluster of TH‐negative neurons in the ventral anterior thalamus. Anterograde transport of GDNF was evident in axons in the pyramidal tract from the cerebral peduncle to the caudal spinal cord. Tissue injury from the intraparenchymal catheter and continuous infusion was confined primarily to a narrow zone surrounding the track and was mild to moderate in severity. J. Comp. Neurol. 461:250–261, 2003. © 2003 Wiley‐Liss, Inc.

[1]  J. van Hattum,et al.  Zinc therapy as the initial treatment for Wilson's disease. , 1988, Archives of neurology.

[2]  L. Olson,et al.  Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial. , 1991, Archives of neurology.

[3]  H. Gundersen,et al.  Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.

[4]  Mark J. West,et al.  New stereological methods for counting neurons , 1993, Neurobiology of Aging.

[5]  G. M. Halliday,et al.  Practical considerations for the use of the optical disector in estimating neuronal number , 1994, Journal of Neuroscience Methods.

[6]  E. Arenas,et al.  GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo , 1995, Neuron.

[7]  W. Mark Saltzman,et al.  Distribution of nerve growth factor following direct delivery to brain interstitium , 1995, Brain Research.

[8]  L Li,et al.  Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Oppenheim,et al.  Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF , 1995, Nature.

[10]  B J Hoffer,et al.  Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys , 1995, The Journal of comparative neurology.

[11]  R. Penn,et al.  Intrastriatal and intraventricular infusion of brain-derived neurotrophic factor in the cynomologous monkey: Distribution, retrograde transport and co-localization with substantia nigra dopamine-containing neurons , 1996, Neuroscience.

[12]  B. Hoffer,et al.  Functional recovery in parkinsonian monkeys treated with GDNF , 1996, Nature.

[13]  A. Buj-Bello,et al.  Characterization of a multicomponent receptor for GDNF , 1996, Nature.

[14]  B. Ponder,et al.  GDNF signalling through the Ret receptor tyrosine kinase , 1996, Nature.

[15]  N. Belluardo,et al.  Complementary and Overlapping Expression of Glial Cell Line-Derived Neurotrophic Factor (GDNF), c-ret Proto-Oncogene, and GDNF Receptor-α Indicates Multiple Mechanisms of Trophic Actions in the Adult Rat CNS , 1997, The Journal of Neuroscience.

[16]  L. Olson,et al.  Cellular and developmental patterns of expression of Ret and glial cell line-derived neurotrophic factor receptor alpha mRNAs , 1997, Experimental Brain Research.

[17]  Zhiming Zhang,et al.  Neuroprotective and neurorestorative properties of GDNF , 1998, Annals of neurology.

[18]  G. Glazner,et al.  Localization of glial cell line‐derived neurotrophic factor receptor alpha and c‐ret mRNA in rat central nervous system , 1998, The Journal of comparative neurology.

[19]  A. Toga,et al.  The Rhesus Monkey Brain in Stereotaxic Coordinates , 1999 .

[20]  R. Killiany,et al.  Age-related neuronal loss from the substantia nigra-pars compacta and ventral tegmental area of the rhesus monkey. , 1999, Journal of neuropathology and experimental neurology.

[21]  W. Saltzman,et al.  Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. Davidson,et al.  Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat , 1999, Gene Therapy.

[23]  L. Olson,et al.  GFRα-1 is expressed in parvalbumin GABAergic neurons in the hippocampus , 2000, Brain Research.

[24]  J. Bloch,et al.  Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. , 2000, Science.

[25]  G. Gerhardt,et al.  Long-term infusion of nonphysiologic solutions into brain parenchyma: effects of pH, osmolarity, and flow rate. , 2000, Comparative medicine.

[26]  K J Burchiel,et al.  DBS and diathermy interaction induces severe CNS damage , 2001, Neurology.

[27]  G. Gerhardt,et al.  Chronic Intracerebral Delivery of Trophic Factors via a Programmable Pump as a Treatment for Parkinsonism. , 2001, Methods in molecular medicine.

[28]  L. Olson,et al.  GFRα‐1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area , 2001 .

[29]  W. Frey,et al.  Delivery of Neurotrophic Factors to the Central Nervous System , 2001, Clinical pharmacokinetics.

[30]  P. Aebischer,et al.  Sustained delivery of GDNF: towards a treatment for Parkinson’s disease , 2001, Brain Research Reviews.

[31]  G. Gerhardt,et al.  Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys , 2002, Neurobiology of Aging.

[32]  R. Bakay,et al.  Lentivirally Delivered Glial Cell Line-Derived Neurotrophic Factor Increases the Number of Striatal Dopaminergic Neurons in Primate Models of Nigrostriatal Degeneration , 2002, The Journal of Neuroscience.

[33]  Richard Grondin,et al.  Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. , 2002, Brain : a journal of neurology.

[34]  R. Segal,et al.  Location, location, location: a spatial view of neurotrophin signal transduction , 2002, Trends in Neurosciences.